Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

cobas EGFR Mutation Test v2-Somatic gene mutation detection system Catalog Recalled by Roche Molecular Systems, Inc. Due to False Mutation Detected results for the exon 20...

Date: September 3, 2021
Company: Roche Molecular Systems, Inc.
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Roche Molecular Systems, Inc. directly.

Affected Products

cobas EGFR Mutation Test v2-Somatic gene mutation detection system Catalog Number :07248563190

Quantity: 507 US; 6,676 ex- US

Why Was This Recalled?

False Mutation Detected results for the exon 20 insertion (Ex20Ins) mutation when using the cobas EGFR Mutation Test v2, may lead to inappropriate treatment

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. has 42 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report